- Current Rating
- Neutral / Needs Confirmation
- Opportunity Score
- 61/100
- Risk Level
- High
- Best Action
- Add to watchlist and monitor for confirmation
Why: ACRV is trading near recent levels (+1.5% today). Overall, the company is reasonably solid. It is in a longer-term sideways range. Price is holding above key moving averages with constructive structure. Risk is elevated — size carefully and require confirmation.
What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.
Avoid if: Price breaks below support on heavy volume or company guidance weakens.
Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.
Research only — not financial advice. Olmem never executes trades.
News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.
- Acrivon Therapeutics: Priced For Failure, Built For Precision (NASDAQ:ACRV) - Seeking AlphaSeeking Alpha · 7/13/2026
- Enterprise value to EBITDA forward of Acrivon Therapeutics, Inc. – NASDAQ:ACRV - TradingViewTradingView · 6/27/2026
- ACRV Forecast — Price Target — Prediction for 2027 - TradingViewTradingView · 6/26/2026
- Acrivon (NASDAQ: ACRV) director granted 20,275 stock options at $1.52 - Stock TitanStock Titan · 6/22/2026
Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.
- Unusual Volume EventACRV volume is 3.1x its average.